AIM β’ KMU EXAM REASONING
KMU Past Paper Practice
Topic 16 β Fluoroquinolones, Sulfonamides and Trimethoprim
3rd Year MBBS β’ 20 A-type Single Best Answer MCQs
MCQ 1
Question:
A 54-year-old man receives an adequate dose of a fluoroquinolone for a susceptible bacterial infection. Several hours after the plasma concentration has fallen below the MIC, bacterial growth remains suppressed. Which pharmacodynamic property best explains this observation?
Options:
Time-dependent bacteriostasis
Irreversible plasma protein binding
Enterohepatic drug recycling
Post-antibiotic effect
Delayed renal filtration
Correct Answer: Post-antibiotic effect
Explanation: Fluoroquinolones produce a post-antibiotic effect, so bacterial growth may remain suppressed after drug concentration falls below the MIC.
MCQ 2
Question:
A patient has community-acquired pneumonia caused by an atypical respiratory pathogen. A fluoroquinolone is considered because the organism lacks the typical extracellular behavior of many bacteria. Which feature of the class best supports activity in this setting?
Options:
Activity limited to urinary pathogens
Useful activity against atypical organisms
Dependence on bacterial folate uptake
Restriction to gram-positive cocci
Dependence on cell-wall synthesis
Correct Answer: Useful activity against atypical organisms
Explanation: Fluoroquinolones have activity against important atypical respiratory pathogens such as Legionella, Mycoplasma and Chlamydia.
MCQ 3
Question:
A microbiology laboratory studies a gram-positive isolate exposed to a fluoroquinolone. DNA replication is disrupted because separation of newly replicated bacterial chromosomes is impaired. Which enzyme is particularly important as a target in many gram-positive organisms?
Options:
Dihydrofolate reductase
Dihydropteroate synthase
Penicillin-binding protein
RNA polymerase
Topoisomerase IV
Correct Answer: Topoisomerase IV
Explanation: Topoisomerase IV is an important fluoroquinolone target in many gram-positive bacteria and is required for proper separation of replicated chromosomes.
MCQ 4
Question:
A 63-year-old diabetic patient develops unexpected fluctuations in blood glucose after starting a fluoroquinolone. No change has been made to the patient’s antidiabetic regimen. Which recognized adverse effect best accounts for this finding?
Options:
Dysglycemia
Crystalluria
Megaloblastic change
Bilirubin displacement
Folate antagonism
Correct Answer: Dysglycemia
Explanation: Some fluoroquinolones can disturb glucose regulation and produce clinically relevant increases or decreases in blood glucose.
MCQ 5
Question:
A child with a serious bacterial infection is being evaluated for fluoroquinolone therapy. The clinician considers the benefits but also recognizes a traditional concern regarding use of this class during growth. Which tissue is primarily involved in this concern?
Options:
Developing renal glomeruli
Immature hepatic lobules
Developing articular cartilage
Growing peripheral nerves
Immature bone marrow
Correct Answer: Developing articular cartilage
Explanation: Fluoroquinolones have traditionally been used cautiously in growing children because of concern about toxicity to developing cartilage and musculoskeletal tissues.
MCQ 6
Question:
A bacterial culture exposed to a fluoroquinolone shows accumulation of abnormal DNA structures and failure of normal replication. Which cellular event is most directly disrupted by inhibition of DNA gyrase?
Options:
Formation of tetrahydrofolate
Cross-linking of peptidoglycan
Assembly of ribosomal proteins
Transcription of messenger RNA
Control of bacterial DNA supercoiling
Correct Answer: Control of bacterial DNA supercoiling
Explanation: DNA gyrase controls DNA supercoiling during replication; its inhibition disrupts proper DNA handling and contributes to the bactericidal action of fluoroquinolones.
MCQ 7
Question:
A 68-year-old patient with reduced renal function requires antibacterial therapy. The clinician reviews the elimination characteristics of individual fluoroquinolones rather than assuming that all members of the class behave identically. Which drug has substantial non-renal elimination?
Options:
Norfloxacin
Moxifloxacin
Nalidixic acid
Sulfamethoxazole
Trimethoprim
Correct Answer: Moxifloxacin
Explanation: Moxifloxacin differs from several other fluoroquinolones because it undergoes substantial non-renal elimination, an important pharmacokinetic distinction.
MCQ 8
Question:
A student compares ciprofloxacin, norfloxacin and ofloxacin with later respiratory fluoroquinolones. Which antimicrobial characteristic is most strongly associated with this earlier fluoroquinolone group?
Options:
Predominant anaerobic activity
Selective antifungal activity
Exclusive pneumococcal activity
Strong aerobic gram-negative activity
Selective mycobacterial activity
Correct Answer: Strong aerobic gram-negative activity
Explanation: Earlier fluoroquinolones are particularly recognized for strong activity against aerobic gram-negative organisms, whereas later agents gained greater respiratory gram-positive activity.
MCQ 9
Question:
A topical antibacterial preparation is selected because local treatment is required without relying on systemic absorption. The active agent belongs to the sulfonamide group. How should this preparation be classified?
Options:
Topical sulfonamide
Systemic quinolone
Respiratory fluoroquinolone
Folate-reductase inhibitor
Non-fluorinated quinolone
Correct Answer: Topical sulfonamide
Explanation: Sulfonamides may be classified as systemically absorbed, poorly absorbed or topical according to how and where they are used.
MCQ 10
Question:
A susceptible bacterium is exposed to sulfamethoxazole. The drug competes with a normal bacterial metabolite during folate synthesis. Which structural relationship is responsible for this competitive action?
Options:
Analogy to tetrahydrofolate
Analogy to dihydrofolate
Analogy to para-aminobenzoic acid
Analogy to bacterial DNA
Analogy to peptidoglycan
Correct Answer: Analogy to para-aminobenzoic acid
Explanation: Sulfonamides resemble PABA structurally and therefore compete with it at dihydropteroate synthase during bacterial folate synthesis.
MCQ 11
Question:
A bacterium remains susceptible to the target-enzyme action of a sulfonamide, but laboratory testing shows that little drug accumulates inside the organism. Which resistance mechanism best fits this finding?
Options:
Increased DNA supercoiling
Enhanced chromosome separation
Reduced folate utilization
Reduced permeability or increased efflux
Increased topoisomerase activity
Correct Answer: Reduced permeability or increased efflux
Explanation: Sulfonamide resistance can result from reduced intracellular drug accumulation through decreased permeability or increased drug efflux.
MCQ 12
Question:
A microbiologist compares sulfamethoxazole with trimethoprim in a susceptible organism. After trimethoprim exposure, production of an essential reduced folate cofactor decreases. Which conversion has been directly inhibited?
Options:
PABA to dihydropteroate
DNA supercoils to relaxed DNA
Peptidoglycan precursors to cell wall
RNA nucleotides to messenger RNA
Dihydrofolate to tetrahydrofolate
Correct Answer: Dihydrofolate to tetrahydrofolate
Explanation: Trimethoprim inhibits bacterial dihydrofolate reductase, preventing conversion of dihydrofolate into tetrahydrofolate.
MCQ 13
Question:
A patient receiving trimethoprim develops an increased serum potassium level. Renal function was stable before treatment. Which drug effect most directly contributes to this electrolyte abnormality?
Options:
Increased intestinal potassium absorption
Reduced renal potassium excretion
Increased hepatic potassium release
Reduced plasma potassium binding
Increased intracellular potassium breakdown
Correct Answer: Reduced renal potassium excretion
Explanation: Trimethoprim can reduce renal potassium excretion, causing potassium retention and clinically important hyperkalemia in susceptible patients.
MCQ 14
Question:
A neonate is inadvertently exposed to a sulfonamide. The pediatrician is concerned that the drug may increase the concentration of unbound bilirubin in plasma. Which pharmacological event produces this risk?
Options:
Displacement of bilirubin from albumin
Inhibition of bilirubin production
Chelation of bilirubin in plasma
Increased renal bilirubin filtration
Increased bilirubin protein synthesis
Correct Answer: Displacement of bilirubin from albumin
Explanation: Sulfonamides can displace bilirubin from albumin, increasing free bilirubin that may enter the immature neonatal brain.
MCQ 15
Question:
A patient with G6PD deficiency develops anemia after receiving a sulfonamide. The blood picture is compatible with accelerated destruction of erythrocytes. Which mechanism best explains this susceptibility?
Options:
Failure of folate absorption
Reduced bilirubin binding
Reduced protection from oxidative injury
Inhibition of DNA topoisomerase
Precipitation inside erythrocytes
Correct Answer: Reduced protection from oxidative injury
Explanation: G6PD-deficient erythrocytes have impaired antioxidant protection, making them more vulnerable to sulfonamide-associated oxidative hemolysis.
MCQ 16
Question:
A patient taking phenytoin has been stable for months. After a sulfonamide is added, the patient develops nystagmus and unsteadiness. Which property of phenytoin makes this interaction clinically important even when the increase in drug exposure is modest?
Options:
Very poor oral absorption
Narrow therapeutic range
Exclusive renal elimination
Complete absence of protein binding
Very short duration of action
Correct Answer: Narrow therapeutic range
Explanation: Phenytoin has a narrow therapeutic range, so reduced clearance or increased active exposure caused by sulfonamides can readily produce toxicity.
MCQ 17
Question:
A laboratory compares bacterial folate synthesis with human folate handling. Sulfonamides can selectively interfere with bacterial metabolism because bacteria perform a step that human cells do not rely on in the same way. Which process provides this selective target?
Options:
Replication of mitochondrial DNA
Formation of human plasma proteins
Synthesis of membrane cholesterol
Metabolism of extracellular glucose
De novo bacterial folate synthesis
Correct Answer: De novo bacterial folate synthesis
Explanation: Bacteria synthesize folate through a pathway involving PABA, providing targets such as dihydropteroate synthase that can be selectively inhibited by sulfonamides.
MCQ 18
Question:
A bacterial infection responds poorly to a sulfonamide given alone but responds to trimethoprim-sulfamethoxazole when susceptibility is confirmed. Which pharmacological consequence of using the two drugs together contributes to the greater antibacterial effect?
Options:
Both drugs accumulate exclusively in urine
Both drugs inhibit bacterial topoisomerases
One drug prevents gastrointestinal absorption of the other
Two successive metabolic steps are inhibited
One drug prevents renal elimination of the other
Correct Answer: Two successive metabolic steps are inhibited
Explanation: Co-trimoxazole produces sequential blockade of bacterial folate metabolism, giving stronger antibacterial activity than either component alone against susceptible organisms.
MCQ 19
Question:
A susceptible organism is exposed to sulfamethoxazole. Folate production falls, followed by impaired formation of compounds needed for bacterial growth. Which downstream cellular process is most directly affected by this folate deficiency?
Options:
Synthesis of nucleic-acid precursors
Cross-linking of peptidoglycan chains
Formation of bacterial ribosomes
Assembly of membrane phospholipids
Secretion of bacterial exotoxins
Correct Answer: Synthesis of nucleic-acid precursors
Explanation: Tetrahydrofolate derivatives are required for synthesis of nucleic-acid precursors, so folate pathway inhibition interferes with bacterial nucleic-acid production.
MCQ 20
Question:
A patient receives an oral fluoroquinolone for a susceptible infection. The clinician aims for adequate peak drug exposure because the antibacterial effect becomes stronger as exposure rises relative to the organism’s susceptibility. Which therapeutic principle is being applied?
Options:
Folate-dependent bacteriostasis
Time-above-MIC dependence alone
Concentration-dependent antibacterial activity
Protein-binding-dependent bacterial killing
Renal-clearance-dependent bacterial killing
Correct Answer: Concentration-dependent antibacterial activity
Explanation: Fluoroquinolones exhibit concentration-dependent killing, so greater exposure relative to bacterial susceptibility generally produces greater antibacterial activity.